018241655

PFENEX BIOPHARMACEUTICALS

---

May 18, 2020

Trademark Summary

The trademark application PFENEX BIOPHARMACEUTICALS was filed by Pfenex Inc.,, a U.S. corporation (the "Applicant"). The application was published for oppositions on August 29, 2021, and it was registered by office on December 6, 2021 without any oppositions.

The application was filed in Danish (English was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with Pharmaceutical preparations, namely, pharmaceuticals used for stimulating white blood cell production, the prevention and treatment of bone and skeletal diseases, and the treatment of cancer, cardiovascular, gastrointestinal, neurological, respiratory, ocular, dermatological, pulmonary, metabolic, infectious, and inflammatory conditions and pharmaceutical preparations for use in connection with protein therapies..
• The mark was filed in class 42 with Research and development in connection with protein therapies for use in pharmaceutical products and Laboratory services, and research and development in the field of pharmaceutical research, namely conducting expression of engineered proteins..